Senate Bill Would Ban PBM "Spread Pricing" in Medicaid, Open Medicare Drug Networks
Also known as: PBM Price Transparency and Accountability Act
Legislative Progress
Impact Analysis
Key Points
Milestones
What Happens Next
Projected impacts based on AI analysis
Related News
3 articlesPBM Reforms, Restoration of Science Cuts Seen in $1.2T Spending Deal for 2026
The $1.2 trillion spending package passed in February 2026 includes PBM reforms that prohibit price-linked remuneration in Medicare Part D, ban spread pricing in Medicaid, and ensure reasonable pharmacy network contracting. The bill also expands HHS reporting and audit authority.

Senate leaders introduce bipartisan PBM reform bill
The bipartisan Senate bill aims to fix market distortions by mandating PBMs pass Medicaid payments directly to pharmacies and requiring participation in the NADAC survey. It also reinforces requirements for Medicare plans to contract with any pharmacy meeting standard terms.
Lawmakers introduce comprehensive PBM reform bill
A bipartisan group of House leaders introduced the Pharmacists Fight Back Act, which aligns with the Senate's PBM Price Transparency and Accountability Act. The legislation seeks to create a transparent reimbursement model using market-based pricing benchmarked to the NADAC.